Kendric Speagle

VivaMed partners with medical research universities worldwide to take drug assets from late preclinical development to clinical proof of concept by leveraging strategic partnerships with research scientists, clinicians, CRO's, manufacturers, and scaled life sciences companies. We focus on developing therapeutics for chronic conditions that are resistant to conventional standards of care, such as CNS, Rare Disease, Metabolic, Cardiopulmonary, and Cerebrovascular disorders.